Rankings
▼
Calendar
ESPR Q3 2016 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$512M
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$17M
EPS (Diluted)
$-0.77
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$264M
Total Liabilities
$10M
Stockholders' Equity
$254M
Cash & Equivalents
$47M
← FY 2016
All Quarters
Q4 2016 →
